Hepatic Impairment Completed Phase 1 Trials for Apalutamide (DB11901)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02524717A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic FunctionTreatment